securities fraud

Class action lawsuit filed against agilon health for allegedly making false statements about 2026 financial guidance and misrepresenting risk reduction initiatives' financial impact.

Varonis Systems faces class action lawsuit for allegedly making false statements about SaaS conversion capabilities, causing inflated stock prices during February-October 2025.

Class action lawsuit filed against Franklin BSP Realty Trust alleging false statements about dividend sustainability. Covers investors who purchased shares November 2024-February 2026.

Portnoy Law Firm sues Corcept Therapeutics over alleged misrepresentations about drug candidate relacorilant, following FDA rejection that caused stock to plummet 50%.

LAKE faces securities class action for alleged misstatements about operational performance and tariff strategies. Investors have until April 24, 2026 deadline to join.

Class action lawsuits filed against PayPal for misleading revenue projections and REGENXBIO for concealing gene therapy safety concerns, both triggering significant stock declines.

Mereo BioPharma faces securities lawsuit alleging misrepresentations about Phase 3 trial results for setrusumab, causing investor losses.

Law firm investigates Chemed Corporation for potential securities violations after missing earnings guidance by $0.61 per share and $19.8 million in revenue.

PayPal faces securities fraud lawsuit alleging material misstatements about revenue projections. Stock dropped 20.3% after CEO replacement and missed earnings disclosure.

NuScale Power faces shareholder lawsuit alleging false statements about ENTRA1 partnership qualifications and undisclosed risks. Stock dropped 12% after revealing $495M payment and $532M quarterly loss.

Navan IPO investors with losses over $100,000 have until April 24, 2026 to file for lead plaintiff status in a class action alleging the company concealed marketing expense increases before going public.

Ultragenyx faces securities lawsuit over delayed disclosure of failed Phase 3 trial. Investors must file lead plaintiff claims by April 6, 2026.

Kyndryl faces securities lawsuit after disclosing internal control weaknesses and delayed 10-Q filing. Stock dropped 21.8% following CFO and General Counsel departures.

BellRing Brands faces securities lawsuit alleging material non-disclosure from November 2024 to August 2025. Stock fell 52% after two guidance cuts amid retail inventory reductions and competition.

Enphase Energy faces securities class action for alleged disclosure failures. Lead plaintiff deadline is April 20, 2026 for investors with losses exceeding $100,000.

CoreWeave faces securities class action for allegedly omitting material disclosures about operational risks and supply chain vulnerabilities. Investors with losses over $100K must apply by March 13, 2026.

Rosen Law Firm sues Enphase Energy for allegedly making false statements about inventory management and financial guidance. Class action deadline April 20, 2026.

Class action lawsuit filed against uniQure for allegedly making false statements about FDA approval status and BLA submission timelines, misleading investors.

PayPal faces securities fraud lawsuit for allegedly misleading investors about growth targets and revenue outlook. Stock fell 20% after disappointing earnings and CEO departure.

Driven Brands stock plummets 40% after restating financials due to multi-year accounting errors including improper revenue recognition and lease accounting. Securities fraud probe launched.